We know the retail price of Qbrexza is $690/mnth. BOT have said Sofdra will be similiar, but with a little bit of a premium due to its superiority. BOT also advise this has been agreed to by all of the main players in the insurance world (I think they quoted 20 or so insurance companies).
We also know, that the actual costs for people that are insured is between $0-$50 cash out of pocket.
We know that more than 90% of the available market is covered by health insurance (i.e. most US citizens actually have commercial health insurance). It's hard to imagine actual cost of a script for the end-user being that influential overall - unless you're part of the 10% that unfortunately doesn't have insurance.
BOT - Anything but charting, page-8378
-
- There are more pages in this discussion • 1,872 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.8¢ |
Change
-0.008(1.81%) |
Mkt cap ! $737.5M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 41.0¢ | 40.0¢ | $1.885M | 4.643M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 945008 | 40.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 410541 | 21 |
View Market Depth
| Last trade - 13.21pm 04/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |